NEW YORK, NY / ACCESS Newswire / February 21, 2025 / If you suffered a loss on your Monolithic Power Systems Inc. (NASDAQ:MPWR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/monolithic-lawsuit-submission-form?prid=131330&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 21, 2025 / If you suffered a loss on your Nextracker Inc. (NASDAQ:NXT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/nextracker-inc-lawsuit-submission-form?prid=131357&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 21, 2025 / If you suffered a loss on your TELUS International (Cda) Inc. (NYSE:TIXT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/telus-international-lawsuit-submission-form?prid=131356&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 21, 2025 / If you suffered a loss on your Grocery Outlet Holding Corp. (NASDAQ:GO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/grocery-outlet-holding-corp-lawsuit-submission-form?prid=131343&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 21, 2025 / If you suffered a loss on your Transocean Ltd. (NYSE:RIG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transocean-ltd-lawsuit-submission-form?prid=131345&wire=1 or contact Joseph E.

NEW YORK, NY / ACCESS Newswire / February 21, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=131341&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 21, 2025 / If you suffered a loss on your Crocs, Inc. (NASDAQ:CROX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/crocs-inc-lawsuit-submission-form?prid=131344&wire=1 or contact Joseph E. Levi, Esq.

Astronics' stock rebounded after issuing convertible notes, outperforming the S&P 500, and I maintain a strong buy rating with a $28 price target. Preliminary Q4 revenues of $208-$210 million met high-end guidance, indicating strong demand and a healthy book-to-bill ratio, with Boeing deliveries resuming. 2025 revenue outlook shows 3-8% growth, but litigation risks could impact free cash flow, potentially zeroing it through 2026 if the court sides with Lufthansa.

JPMorgan Chase (NYSE: JPM) the largest bank in the U.S by assets, recently reported a strong fourth-quarter performance, with revenue climbing 10% year-over-year to $43.74 billion and net income surging 50% to $14 billion, exceeding Wall Street expectations.

SALT LAKE CITY , Feb. 21, 2025 /PRNewswire/ -- Scott McLean, President and COO of Zions Bancorporation, N.A. (NASDAQ: ZION), will make a presentation at the RBC Capital Markets Global Financial Institutions Conference on Tuesday, March 4 th at 4:00 pm Eastern.

ADBE shares are benefiting from strong demand for its creative products and expanding clientele amid increasing competition and stretched valuation.

Salesforce's Q4 performance is likely to reflect the benefits of the growing adoption of generative AI-enabled solutions and continued cloud migration.

Walmart tops earnings and revenue estimates but warns of slower sales growth.

While the top- and bottom-line numbers for Arbor Realty Trust (ABR) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

While the top- and bottom-line numbers for TDS (TDS) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Frontline (FRO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Amneal (AMRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Apellis Pharmaceuticals (APLS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Owens & Minor (OMI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

RadNet (RDNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.